Degenhardt L, Charlson F, Ferrari A, Santomauro D, Erskine H, Mantilla-Herrara A, et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2013;2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;5:987–1012.
Formanek T, Krupchanka D, Mlada K, Winkler P, Jones PB. Mortality and life-years lost following subsequent physical comorbidity in people with pre-existing substance use disorders: a national registry-based retrospective cohort study of hospitalised individuals in Czechia. Lancet Psychiatry. 2022;9:957–68.
Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379:55–70.
Anderson DM, Fe HT, Liang Y, Sabia JJ. Recreational marijuana laws and teen marijuana Use, 1993–2021. JAMA Psychiat. 2024;81:840–2.
Castaldelli-Maia JM, Wang YP, Brunoni AR, Faro A, Guimaraes RA, Lucchetti G, et al. Burden of disease due to amphetamines, cannabis, cocaine, and opioid use disorders in South America, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019. Lancet Psychiatry. 2023;10:85–97.
Article PubMed Central PubMed Google Scholar
Han B, Compton WM, Jones CM, Einstein EB, Volkow ND. Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among US Adults. JAMA Psychiat. 2021;78:1329–42.
Zhang L, Yao H, Li L, Du Rietz E, Andell P, Garcia-Argibay M, et al. Risk of cardiovascular diseases associated with medications used in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. JAMA Netw Open. 2022;5:e2243597.
Article PubMed Central PubMed Google Scholar
Gobbi G, Atkin T, Zytynski T, Wang S, Askari S, Boruff J, et al. Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: a systematic review and meta-analysis. JAMA Psychiat. 2019;76:426–34.
Clark DB, Martin CS, Cornelius JR. Adolescent-onset substance use disorders predict young adult mortality. J Adolesc Health. 2008;42:637–9.
Article PubMed Central PubMed Google Scholar
Kun B, Urban R, Paksi B, Griffiths MD, Richman MJ, Demetrovics Z. The effects of trait emotional intelligence on adolescent substance use: findings from a hungarian representative survey. Front Psychiatry. 2019;10:367.
Article PubMed Central PubMed Google Scholar
Steinfeld MR, Torregrossa MM. Consequences of adolescent drug use. Transl Psychiatry. 2023;13:313.
Article PubMed Central PubMed Google Scholar
Kang J, Kim HJ, Kim T, Lee H, Kim M, Lee SW, et al. Prenatal opioid exposure and subsequent risk of neuropsychiatric disorders in children: nationwide birth cohort study in South Korea. BMJ. 2024;385:e077664.
Article CAS PubMed Central PubMed Google Scholar
Ma C, Bovet P, Yang L, Zhao M, Liang Y, Xi B. Alcohol use among young adolescents in low-income and middle-income countries: a population-based study. Lancet Child Adolesc Health. 2018;2:415–29.
Smith L, López Sánchez GF, Oh H, Jacob L, Kostev K, Rahmati M, et al. Temporal trends of physical fights and physical attacks among adolescents aged 12–15 years from 30 countries from Africa, Asia, and the Americas. J Adolesc Health. 2024;74:996–1005.
de Lima Friche AA, Silva UM, Bilal U, Sarmiento OL, de Salles Dias MA, Prado-Galbarro FJ, et al. Variation in youth and young adult homicide rates and their association with city characteristics in Latin America: the SALURBAL study. Lancet Reg Health Am. 2023;20:100476.
PubMed Central PubMed Google Scholar
Mills F, Foster T, Kome A, Munankami R, Halcrow G, Ndungu A, et al. Indicators to complement global monitoring of safely managed on-site sanitation to understand health risks. NPJ Clean Water. 2024;7:58.
Article PubMed Central PubMed Google Scholar
Dieleman JL, Templin T, Sadat N, Reidy P, Chapin A, Foreman K, et al. National spending on health by source for 184 countries between 2013 and 2040. Lancet. 2016;387:2521–35.
Hong S, Son Y, Lee H, Kim S, Kim HJ, Jo H, et al. Global association of secondhand smoke exposure locations and smoking behaviour among adolescents in 99 countries. Acta Paediatr. 2024;113:2048–60.
Fangal VD, Saferali A, Castaldi PJ, Hersh CP, Weiss ST. Distinct physiological, transcriptomic, and imaging characteristics of asthma-COPD overlap compared to asthma and COPD in smokers. EBioMedicine. 2024;110: 105453.
Article PubMed Central PubMed Google Scholar
Asante KO, Atorkey P. Cannabis and amphetamine use among school-going adolescents in sub-Saharan Africa: a multi-country analysis of prevalence and associated factors. BMC Psychiatry. 2023;23:778.
Article PubMed Central PubMed Google Scholar
Osborne A, Aboagye RG, Olorunsaiye CZ, James PB, Bangura C, Seidu AA, et al. Prevalence and predictors of lifetime amphetamine use among in-school adolescents in Sierra Leone. BMJ Open. 2024;14:e080225.
Article PubMed Central PubMed Google Scholar
Wang Q, Wang H. Cannabis and tobacco use among adolescents aged 12–17 years from 16 low- and middle-income countries. J Glob Health. 2023;13:04066.
Article PubMed Central PubMed Google Scholar
Volkow ND, Han B, Einstein EB, Compton WM. Prevalence of substance use disorders by time since first substance use among young people in the US. JAMA Pediatr. 2021;175:640–3.
Article PubMed Central PubMed Google Scholar
Guido PC, Riva N, Calle G, Dell’Orso M, Gatto M, Sberna N, et al. Medicinal cannabis in Latin America: History, current state of regulation, and the role of the pharmacist in a new clinical experience with cannabidiol oil. J Am Pharm Assoc. 2020;60:212–5.
Lapham GT, Matson TE, Bobb JF, Luce C, Oliver MM, Hamilton LK, et al. Prevalence of cannabis use disorder and reasons for use among adults in a US state where recreational cannabis use is legal. JAMA Netw Open. 2023;6:e2328934.
Article PubMed Central PubMed Google Scholar
Kim S, Lee H, Lee J, Lee SW, Kwon R, Kim MS, et al. Short- and long-term neuropsychiatric outcomes in long COVID in South Korea and Japan. Nat Hum Behav. 2024;8:1530–44.
Brumbaugh S, Tuan WJ, Scott A, Latronica JR, Bone C. Trends in characteristics of the recipients of new prescription stimulants between years 2010 and 2020 in the United States: an observational cohort study. EClinicalMedicine. 2022;50:101524.
Article PubMed Central PubMed Google Scholar
Winkelman TNA, Admon LK, Jennings L, Shippee ND, Richardson CR, Bart G. Evaluation of amphetamine-related hospitalizations and associated clinical outcomes and costs in the United States. JAMA Netw Open. 2018;1: e183758.
Article PubMed Central PubMed Google Scholar
Testa A, Weiss DB, Santos MR. Opioid mortality, public health care expenditures, and cross-national homicide rates: findings from 25 OECD countries, 2000–2017. Soc Psychiatry Psychiatr Epidemiol. 2022;57:673–82.
Kruk ME, Gage AD, Joseph NT, Danaei G, García-Saisó S, Salomon JA. Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries. Lancet. 2018;392:2203–12.
Article PubMed Central PubMed Google Scholar
Cheong C, Park J, Park J, Jo H, Lee K, Lee JH, et al. National trends in alcohol consumption, smoking, suicide attempts, and COVID-19 pandemic-related factors among South Korean adolescents, 2012–2022. Asian J Psychiatr. 2024;97:104085.
Strickland JC, Smith MA. The effects of social contact on drug use: behavioral mechanisms controlling drug intake. Exp Clin Psychopharmacol. 2014;22:23–34.
Skaathun B, Strathdee SA, Shrader CH, Nacht CL, Borquez A, Artamonova I, et al. HIV-1 transmission dynamics among people who inject drugs on the US/Mexico border during the COVID-19 pa
Comments (0)